ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 203 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $495,000 | -7.8% | 18,535 | -7.3% | 0.05% | -5.4% |
| Q1 2019 | $537,000 | +66.3% | 20,000 | 0.0% | 0.06% | +55.6% |
| Q4 2018 | $323,000 | -64.7% | 20,000 | -66.7% | 0.04% | -64.4% |
| Q2 2018 | $916,000 | +1.9% | 60,000 | +50.0% | 0.10% | -4.7% |
| Q1 2018 | $899,000 | -25.3% | 40,000 | 0.0% | 0.11% | -25.4% |
| Q4 2017 | $1,204,000 | -20.1% | 40,000 | 0.0% | 0.14% | -27.2% |
| Q3 2017 | $1,507,000 | -9.9% | 40,000 | -33.3% | 0.20% | -13.7% |
| Q2 2017 | $1,673,000 | -18.9% | 60,000 | 0.0% | 0.23% | -23.1% |
| Q1 2017 | $2,063,000 | +19.2% | 60,000 | 0.0% | 0.29% | +19.5% |
| Q4 2016 | $1,730,000 | – | 60,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |